Preliminary Experience of Neuroform Atlas Stenting as a Rescue Treatment after Failure of Mechanical Thrombectomy Caused by Residual Intracranial Atherosclerotic Stenosisopen access
- Authors
- Yi, Ho Jun; Sung, Jae Hoon; Lee, Dong Hoon
- Issue Date
- Mar-2021
- Publisher
- 대한신경외과학회
- Keywords
- Angioplasty; Atherosclerosis; Thrombectomy; Stents; Stroke; Neuroform atlas
- Citation
- Journal of Korean Neurosurgical Society, v.64, no.2, pp 198 - 206
- Pages
- 9
- Journal Title
- Journal of Korean Neurosurgical Society
- Volume
- 64
- Number
- 2
- Start Page
- 198
- End Page
- 206
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/18975
- DOI
- 10.3340/jkns.2020.0146
- ISSN
- 2005-3711
1598-7876
- Abstract
- Objective : The low-profile Neuroform Atlas stent can be deployed directly without an exchange maneuver by navigating into the Gateway balloon. This retrospective study assessed the safety and efficacy of Neuroform Atlas stenting as a rescue treatment after failure of mechanical thrombetomy (MT) for large artery occlusion. Methods : Between June 2018 and December 2019, a total of 31 patients underwent Neuroform Atlas stenting with prior Gateway balloon angioplasty after failure of conventional MT caused by residual intracranial atherosclerotic stenosis (ICAS). Primary outcomes were successful recanalization and patency of the vessel 24 hours after intervention. Secondary outcomes were vessel patency after 14 days and 3-month modified Rankin Scale. Pen-procedural complications, intracerebral hemorrhage (ICH), and 3-month mortality were reviewed. Results : With a 100% of successful recanalization, median value of stenosis was reduced from 79.0% to 23.5%. Twenty-eight patients (90.3%) showed tolerable vessel patency after 14 days. New infarctions occurred in three patients (9.7%) over a period of 14 days; two patient (6.5%) underwent stent occlusion at 24 hours, and the other patient (3 .2 %) with delayed stent occlusion had a non-symptomatic dot infarct. There were no pen-procedural complications. Two patients (6.5%) developed an ICH immediately after the procedure with one of them is symptomatic. Conclusion : Neuroform Atlas stenting seems to be an effective and safe rescue treatment modality for failed MT with residual ICAS, by its high successful recanalization rate with tolerable patency, and low pen-procedural complication rate. Further multicenter and randomized controlled trials are needed to confirm our findings.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Neurosurgery > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/18975)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.